Leo Cancer Care Funding: $150M Raised, Series D (2024)
Leo Cancer Care is based in London, United Kingdom. It has raised $150M in total funding. Latest round: Series D.
Leo Cancer Care funding overview
Leo Cancer Care is based in London, United Kingdom. Leo Cancer Care has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in July 2024. The round record for Leo Cancer Care runs through 2024; nothing later has been disclosed. Investors on record include PR Yu, Eventide Asset Management, Wisconsin Alumni Research Foundation (WARF), Alumni Ventures, Bioshore, Pureland Venture Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
Leo Cancer Care at a glance
Total raised
$150M
Latest round
Series D
Latest round date
July 2024
Headquarters
London, United Kingdom
Notable investors
PR Yu, Eventide Asset Management, Wisconsin Alumni Research Foundation (WARF), Alumni Ventures, Bioshore, Pureland Venture Capital, Yu Galaxy, Junson Capital
Frequently asked about Leo Cancer Care funding
How much has Leo Cancer Care raised?
Leo Cancer Care has raised $150M in total disclosed funding across the rounds on record.
Who has invested in Leo Cancer Care?
PR Yu, Eventide Asset Management, Wisconsin Alumni Research Foundation (WARF), Alumni Ventures, Bioshore, Pureland Venture Capital are named among the investors backing Leo Cancer Care.
What was the latest Leo Cancer Care funding round?
The most recent disclosed round is a Series D, announced in July 2024.
Where is Leo Cancer Care based?
Leo Cancer Care is based in London, United Kingdom.
When did Leo Cancer Care last raise?
The last disclosed Leo Cancer Care round closed in July 2024 at Series D.
Round data for Leo Cancer Care is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in London and backer lists below.
